We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The attorneys general of California and Alaska have issued subpoenas to AstraZeneca seeking information about its marketing practices for Seroquel (quetiapine fumarate), and the SEC has made an “informal inquiry” to the company regarding payments to foreign doctors and government officials, the company said.
AstraZeneca is stopping any further work on an investigative drug for the neurological damage caused by strokes, after it failed to show any effect compared with placebo in a Phase III clinical trial.
IMS Health projections predict a lower growth rate for the global pharmaceutical market in 2007, with the U.S. in particular contributing less due to generic competition and an increase in niche products.
IMS Health projections predict a lower growth rate for the global pharmaceutical market in 2007, with the U.S. in particular contributing less due to generic competition and an increase in niche products.
Nationwide Insurance and Medco have joined to offer small businesses a low-cost prescription plan featuring generic drugs to help provide employees with healthcare benefits.
Regulators and devicemakers pledged to implement many of the Heart Rhythm Society (HRS) recommendations released Sept. 28 that ask the FDA, industry and physicians to do a better job of tracking heart device malfunctions and communicating device adverse event information.